Emerging and Converging Fields of Human Milk Oligosaccharides (Hmos) and the Gut Microbiome

Program Date: 17 July 2017
Publication Date: 31 January 2017
Continuing Education Units: 1.5 Nurse Contact Hours, 1.5 Dietitian CPEU

Course Objectives:

  • Define the function and review the clinical evidence supporting the role of human milk oligosaccharides (HMOs)
  • Describe potential health care and development benefits of 2’-FL HMO in preterm and term infants
  • Describe the colonization of the microbiome
  • CDR Level: 2
  • Suggested Learning Codes: 2060,4150,2000
  • Performance Indicators: 8.1.3, 8.1.4, 8.3.7
  • Media Format(s): Digital (English)
  • Run Time: 90 Minutes

Course Instructor Bio(s)

A headshot of Dr Ardythe Morrow

Ardythe Morrow, PhD MSc

Professor of Pediatrics and Nutrition
Director, Center for Interdisciplinary
Research in Human Milk and Lactation
Global Heath Center
University of Cincinnati

Ardythe L. Morrow, PhD is Professor of Pediatrics, Nutrition and Environmental Health at the University of Cincinnati, and Director of the Center for Interdisciplinary Research in Human Milk and Lactation at Cincinnati Children’s Hospital Medical Center. She co-chairs the campus Nutrition Hot Topics grand rounds and is a founding member of the Global Health Center at Cincinnati Children’s. Trained in epidemiology, nutrition, and infectious disease, the primary focus of her career is has been in human milk protection against infectious and inflammatory gut disorders, growth retardation and the bioactive components of human milk that offer protection. She has been particularly focused on the role of human milk and gut oligosaccharide in infant and child health. She is known for publishing the first functional studies of human milk oligosaccharide protection in human infants. She served as the founder and director of the Division of Biostatistics and Epidemiology from 2001 to 2011 at Cincinnati Children’s Hospital Medical Center. She has achieved more than $25 million dollars in total research funding from NIH, CDC, foundations and industry. She has published more than 150 peer-reviewed papers and 15 chapters, monographs or books. She has served as a reviewer and scientific adviser to NIH, CDC, PAHO and WHO and major nutrition companies, and often sought as an invited speaker. She serves on the editorial board of multiple journals. She loves to mentor and has many former trainees in academia and industry leadership positions. She has ongoing projects in several countries. .

A headshot of Dr Jomay Chow

JoMay Chow, PhD

Senior Research Scientist
R&D Gut Health Platform
Abbott Nutrition

JoMay Chow is a Senior Research Scientist with the Abbott Nutrition R&D Gut Health Platform and is responsible for translational research in the areas of: prebiotics, probiotics, and gastrointestinal microbiology. She is currently a member of the International Scientific Association for Probiotics & Prebiotics (ISAPP) Industry Advisory Committee and the International Life Sciences Institute (ILSI) North America Gut Microbes & Health Committee. Previously, she served on the Abbott Scientific Governing Board’s Human Microbiome Committee to explore future opportunities in this rapidly emerging area. Prior to joining Abbott in 1994, JoMay obtained a Ph.D. from Cornell University and conducted post-doctoral research at the USDA National Center for Agricultural Utilization Research..


You Must LOG IN to Enroll


attended a live program?




continuing medical education courses

Earn CME credits at no cost to you.